Antisoma Research Limited
Records under this name other than patents Antisoma Research Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Antisoma Research Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,420,087 | INTERLEUKIN-12 Targeted to Oncofoetal Fibronectin Formerly held Lapsed on the fee record Ended Apr 16, 2025 · High confidence | Lapsed on the fee record | Ended Apr 16, 2025 | High confidence |
| US 8,114,850 | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin Formerly held Term ended Term ended May 28, 2022 · From the USPTO record | Term ended | Term ended May 28, 2022 | From the USPTO record |
| US 8,648,051 | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin Formerly held Term ended Term ended Mar 1, 2022 · From the USPTO record | Term ended | Term ended Mar 1, 2022 | From the USPTO record |
| US 7,960,540 | Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin Formerly held Term ended Term ended Jun 15, 2020 · From the USPTO record | Term ended | Term ended Jun 15, 2020 | From the USPTO record |
| US 7,314,926 | Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin Formerly held Term ended Term ended Apr 7, 2020 · From the USPTO record | Term ended | Term ended Apr 7, 2020 | From the USPTO record |
| US 6,358,491 | Somatostatin analogs Formerly held Term ended Term ended Sep 16, 2019 · From the USPTO record | Term ended | Term ended Sep 16, 2019 | From the USPTO record |
| US 6,204,366 | Specific binding agents Formerly held Term ended Term ended Mar 20, 2018 · From the USPTO record | Term ended | Term ended Mar 20, 2018 | From the USPTO record |
| US 7,314,296 | Multi-Platform Aircraft Forward Position Light Utilizing LED-Based Light Source Formerly held Lapsed on the fee record Ended Jan 1, 2016 · High confidence | Lapsed on the fee record | Ended Jan 1, 2016 | High confidence |
| US 6,989,390 | Amonafide salts Lapsed on the fee record Ended Jan 24, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jan 24, 2014 | From the USPTO record |
| US 6,217,846 | Synthetic peptides for use in thrombus detection Lapsed on the fee record Ended Apr 17, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2013 | From the USPTO record |